Intrafamilial Variability of Ocular Manifestations of von Hippel-Lindau Disease
- PMID: 34416425
- PMCID: PMC9367018
- DOI: 10.1016/j.oret.2021.08.005
Intrafamilial Variability of Ocular Manifestations of von Hippel-Lindau Disease
Abstract
In this retrospective cohort study, we describe intrafamilial phenotypic variability of retinal hemangioblastoma (RH) in families with von Hippel-Lindau (VHL) disease. Patients with molecularly confirmed VHL evaluated at our institution were identified, and records were reviewed. For individuals with sufficient follow-up and imaging (n=27), the number and location of RHs at the initial and most recent follow-up visits were recorded along with treatment method and systemic manifestations. A strategy for zonal classification of RH location was used. Intrafamilial phenotypic variation was identified in 3 families. Intrafamilial phenotypic variability of RH exists between family members with VHL with the same genetic mutation.
Figures

References
-
- Aronow ME, Wiley HE, Gaudric A, et al. Von Hippel-Lindau Disease: update on pathogenesis and systemic aspects. Retina 2019;39:2243–2253. - PubMed
-
- Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317–1320. - PubMed
-
- Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer 2015;15:55–64. - PubMed
-
- Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy Study Group. Arch Ophthalmol 1989;107:1759–1766. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical